“Because we are realigning our business to focus on population health, we are also refocusing our team in support of this goal,” Mr. Kao said in an emailed statement. “Some of those reductions happened voluntarily ahead of our strategic announcement, as team members looked for long-term opportunities that were better aligned with their experience and interest.”
While Helix’s San Carlos and San Diego outposts will remain open, its San Francisco and Denver offices will shutter. News of the company’s restructuring comes just weeks after Helix announced it was shifting its strategy away from expanding its “app store for DNA” and focusing instead on building partnerships with healthcare providers.
Helix has raised $300 million in funding since its 2015 founding. In that time, it has built partnerships with the Mayo Clinic, National Geographic, Mount Sinai and the statewide Healthy Nevada Project. Genome sequencing giant Illumina ended its years-long relationship with Helix in late April, ahead of the news of the startup’s shift in focus.
More articles about health IT:
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent
Bill calls for $2.2B in federal AI funding
Baystate Health to implement mobile platform to improve physician query process
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
